TuHURA Biosciences (HURA)

• Market cap: $145M
• 1 day: -2.16%
• 5 days: 10.73%
• 1 month: -1.73%
• 3 months: 8.1%
• 6 months: 135.62%
• Year to date: 202.87%
• 1 year: -11.67%
• 5 years: -99.93%
• 10 years: -100%
• Sector: Healthcare
• Industry: Biotechnology

About: TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.

Employees: 22